Evidence map›Paper›PMID 33512482›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Transcontinental Dissemination of the L2b/D-Da Recombinant Chlamydia trachomatis Lymphogranuloma venereum (LGV) Strain: Need of Broad Multi-Country Molecular Surveillance.

Vítor Borges, Joana Isidro, Cristina Correia, Dora Cordeiro, Luís Vieira, Zohra Lodhia, Cândida Fernandes, Ana Maria Rodrigues, Jacinta Azevedo, João Alves and 17 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Anorectal lymphogranuloma venereum among men who have sex with men: a 3-year nationwide survey, France, 2020 to 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  4. Review
  5. Strengthening the genomic surveillance ofFrontiers in microbiology · 2023
    Article
  6. Genome organization and genomics inFrontiers in cellular and infection microbiology · 2023
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 7 institutions in 3 countries.

Vítor BorgesNational Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
Joana IsidroNational Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
Cristina CorreiaNational Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
Dora CordeiroNational Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
Luís VieiraNational Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
Zohra LodhiaNational Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
Cândida FernandesCentro Hospitalar e Universitário de Lisboa Central, Lisbon, Portugal.
Ana Maria RodriguesCentro Hospitalar e Universitário de Lisboa Central, Lisbon, Portugal.
Jacinta AzevedoLapa Health Centre, Lisbon, Portugal.
João AlvesLapa Health Centre, Lisbon, Portugal.
João RoxoCheckpointLX, Grupo de Ativistas em Tratamentos, Lisbon, Portugal.
Miguel RochaCheckpointLX, Grupo de Ativistas em Tratamentos, Lisbon, Portugal.
Rita Côrte-RealCentro Hospitalar e Universitário de Lisboa Central, Lisbon, Portugal.
Cristina ToscanoCentro Hospitalar Lisboa Ocidental, Lisbon, Portugal.
Maria Ana PessanhaCentro Hospitalar Lisboa Ocidental, Lisbon, Portugal.
Israel NissanNational Public Health Laboratories, Tel Aviv, Israel.
Shlomo PiloNational Public Health Laboratories, Tel Aviv, Israel.
Efrat RormanNational Public Health Laboratories, Tel Aviv, Israel.
Zeev DveyrinNational Public Health Laboratories, Tel Aviv, Israel.
Yossi PaitanDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine & Tel Aviv University, Tel Aviv, Israel.
Haim ParanDepartment of General Surgery A, Meir Medical Center, Kfar Saba, Israel.
Gal Wagner-KolaskoDepartment of Family Medicine, Clalit Gan-Meir LGBT Clinic, Tel Aviv, Israel.
Jennifer BeirnesPublic Health Agency of Canada, Winnipeg, Manitoba, Canada.
Suzanne GibbonsPublic Health Agency of Canada, Winnipeg, Manitoba, Canada.
Alberto SeveriniPublic Health Agency of Canada, Winnipeg, Manitoba, Canada.
Maria José BorregoNational Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
João Paulo GomesNational Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
National Institute of Health Dr. Ricardo Jorge · PTCentro Hospitalar de Lisboa Central · PTPublic Health Agency of Canada · CACentro Hospitalar de Lisboa Ocidental · PTClalit Health Services · ILMeir Medical Center · ILTel Aviv University · IL

Funding

COMPETEFundos FEDERFundos Nacionais UID/BIM/00009/2019GenomePT project POCI-01-0145-FEDER-022184
6 · The paper itself

Abstract

Previously, we identified a Chlamydia trachomatis lymphogranuloma venereum (LGV) recombinant strain possessing a non-LGV ompA genotype. Here, culture-independent genome sequencing confirms its circulation in Europe, Middle East, and North America, and unveils emergence of antibiotic resistance. Broad surveillance is needed.

Indexed as

Chlamydia trachomatisLymphogranuloma VenereumBase SequenceEuropeGenotypeHomosexuality, MaleHumansMaleChlamydia trachomatisfluoroquinolones resistanceintercontinental disseminationlymphogranuloma venereum (LGV)recombination

Identifiers

PMID33512482
OpenAlexW3122173354

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.